Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Visgo Therapeutics

Out of Business LATEST DEAL TYPE

Developer of medical therapies designed to treat joint disease such as osteoarthritis (OA). The company's medical therapies are microparticle that can be loaded with drugs and delivered by intra-articular (IA) injection for release over time within the joint, with minimal systemic exposure, enabling patients to get relief from joint pain and osteoarthritis.

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Other Industries
Drug Delivery
Primary Office
  • 67 South Bedford Street
  • Suite 400W
  • Burlington, MA 01803
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Visgo Therapeutics’s full profile, request a free trial.

Visgo Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jul-2017 00000 Completed Out of Business
1. Angel (individual) 05-Mar-2015 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Visgo Therapeutics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Flexion Therapeutics Formerly VC-backed Burlington, MA 000 00000 00000000000 00000
0000000 0000000 Venture Capital-Backed Watertown, MA 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Visgo Therapeutics Executive Team (3)

Name Title Board
Jeanne Bertonis Co-Founder, Chief Executive Officer & Board Member
Pamela Hay JD Co-Founder, President & Chairman
Peter Rock Chief Financial Officer

Visgo Therapeutics Board Members (1)

Name Representing Role Since Contact
Pamela Hay JD Visgo Therapeutics Co-Founder, President & Chairman 000 0000